Phase 2 test of QBS72S for breast cancer leptomeningeal disease.

Nagpal S, Carlson-Clarke B, Rout SS, Trinh TTH, Roy-O'Reilly M, Tedjakusuma SN, Taiwo R, Harary PM, Granucci M, Chernikova SB, Bertrand S, Therkelsen KE, Han SS, Gu B, Bharani KL, Newman JM, Barisano G, Umeh-Garcia MC, Herrick D, Vogel H, Arora M, Samos CH, Soltys SG, Pollom EL, Rahimy E, Iv M, Melisko ME, Hayden Gephart M

Open source

DOI: 10.1093/neuonc/noag177
Published: 2026 Aug 7
Container: Neuro-oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/neuonc/noag177,
  title = {Phase 2 test of QBS72S for breast cancer leptomeningeal disease.},
  author = {Nagpal S and Carlson-Clarke B and Rout SS and Trinh TTH and Roy-O'Reilly M and Tedjakusuma SN and Taiwo R and Harary PM and Granucci M and Chernikova SB and Bertrand S and Therkelsen KE and Han SS and Gu B and Bharani KL and Newman JM and Barisano G and Umeh-Garcia MC and Herrick D and Vogel H and Arora M and Samos CH and Soltys SG and Pollom EL and Rahimy E and Iv M and Melisko ME and Hayden Gephart M},
  year = {2026},
  journal = {Neuro-oncology},
  doi = {10.1093/neuonc/noag177},
  url = {https://doi.org/10.1093/neuonc/noag177}
}

RIS

TY  - JOUR
TI  - Phase 2 test of QBS72S for breast cancer leptomeningeal disease.
AU  - Nagpal S
AU  - Carlson-Clarke B
AU  - Rout SS
AU  - Trinh TTH
AU  - Roy-O'Reilly M
AU  - Tedjakusuma SN
AU  - Taiwo R
AU  - Harary PM
AU  - Granucci M
AU  - Chernikova SB
AU  - Bertrand S
AU  - Therkelsen KE
AU  - Han SS
AU  - Gu B
AU  - Bharani KL
AU  - Newman JM
AU  - Barisano G
AU  - Umeh-Garcia MC
AU  - Herrick D
AU  - Vogel H
AU  - Arora M
AU  - Samos CH
AU  - Soltys SG
AU  - Pollom EL
AU  - Rahimy E
AU  - Iv M
AU  - Melisko ME
AU  - Hayden Gephart M
PY  - 2026
JO  - Neuro-oncology
DO  - 10.1093/neuonc/noag177
UR  - https://doi.org/10.1093/neuonc/noag177
ER  -

APA

S, N., B, C., SS, R., TTH, T., M, R., SN, T., R, T., PM, H., M, G., SB, C., S, B., KE, T., SS, H., B, G., KL, B., JM, N., G, B., MC, U., D, H., H, V., M, A., CH, S., SG, S., EL, P., E, R., M, I., ME, M., & M, H. G. (2026). Phase 2 test of QBS72S for breast cancer leptomeningeal disease.. Neuro-oncology. https://doi.org/10.1093/neuonc/noag177

Source records

pubmed · retrieved 2026-09-26T05:45:51.940Z